ZNF93 Increases Resistance to ET-743 (Trabectedin; Yondelis®) and PM00104 (Zalypsis®) in Human Cancer Cell Lines
Zhenfeng Duan, Edwin Choy, David Harmon et al. · 2009
Read ZNF93 Increases Resistance to ET-743 (Trabectedin; Yondelis®) and PM00104 (Zalypsis®) in Human Cancer Cell Lines by Zhenfeng Duan, Edwin Choy, David Harmon et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006967.txt.
Description
Zhenfeng Duan, Edwin Choy, David Harmon, and colleagues studied drug resistance in cancer cells in PLOS ONE in 2009. Two marine-derived drugs, trabectedin and PM00104, can kill tumors. With long treatment, cancers often learn to resist them. The reasons for that resistance were not known.
Working with human cancer cell lines, the team singled out a gene called ZNF93. Raising this gene increased resistance to both drugs. That makes ZNF93 a suspect worth testing in patients. If it predicts resistance, doctors could choose other treatments for patients whose tumors carry it.
Catalog record
| CREATOR | Zhenfeng Duan, Edwin Choy, David Harmon et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006967